Want to see AEON full AI Analyst Report?
AEON Biopharma (AEON) Ownership - Who Owns AEON Biopharma?
AEON Biopharma (AEON) Ownership Overview
- 31.38% Insiders
- 0.27% Mutual Funds
- 0.02% Other Institutional Investors
- 0.15% ETFs
- 68.18% Public Companies and Individual Investors
The ownership structure of AEON Biopharma (AEON) stock is a mix of institutional, retail, and individual investors. Approximately 0.45% of the company’s stock is owned by Institutional Investors, 31.38% is owned by Insiders, and 68.18% is owned by Public Companies and Individual Investors.
The ownership structure of AEON Biopharma (AEON) stock is a mix of institutional, retail, and individual investors. Approximately 0.45% of the company’s stock is owned by Institutional Investors, 31.38% is owned by Insiders, and 68.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 20, 2026 | Timothy Lynch | $241,500 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Timothy Lynch | 6,500,000 | Insider | 11.00% | 1,781,000 |
| Robert E. Bancroft | 3,177,103 | Insider | 5.38% | 870,526 |
| Oh Chad | 2,183,436 | Insider | 3.70% | 598,261 |
| Wilson Alexander Blair | 2,183,005 | Insider | 3.69% | 598,143 |
| Jennifer Sy | 1,501,176 | Insider | 2.54% | 411,322 |
| Forth Marc | 973,231 | Insider | 1.65% | 266,665 |
| John Bencich | 754,717 | Insider | 1.28% | 206,792 |
| Jost Fischer | 489,469 | Insider | 0.83% | 134,115 |
| Shelley Thunen | 258,705 | Insider | 0.44% | 70,885 |
| Carter Eric G | 258,705 | Insider | 0.44% | 70,885 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 90,529 | Institution | 0.15% | 24,805 |
| Fidelity Concord Street Trust | 70,048 | Institution | 0.12% | 19,193 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXF ETF | 90,529 | Institution | 0.15% | 27,159 |
FAQ
Who Owns AEON Biopharma (AEON)?
According to the latest TipRanks data, approximately 0.45% of the company's stock is held by institutional investors, 31.38% is held by insiders, and 68.18% is held by public companies and individual investors.
What percentage of AEON Biopharma (AEON) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.45% of AEON Biopharma (AEON) stock is held by institutional investors: 0.27% by mutual funds, 0.15% by ETFs and 0.02% by other institutional investors.
What percentage of AEON Biopharma (AEON) stock is held by retail investors?
According to the latest TipRanks data, approximately 68.18% of AEON Biopharma (AEON) stock is held by public companies and individual investors.
Who owns the most shares of AEON Biopharma (AEON)?
Timothy Lynch owns the most shares of AEON Biopharma (AEON).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.